Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check77 days agoChange DetectedThe webpage has been updated to include new information about a clinical study involving HIV infections, specifically detailing the treatment regimen of 50 mg DTG + 300 mg 3TC FDC. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference26%
Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.